<DOC>
	<DOCNO>NCT00530062</DOCNO>
	<brief_summary>This research study design compare single-dose effectiveness albuterol-HFA-BAI ( breath activate inhaler ) albuterol-HFA-MDI ( meter dose inhaler ) asthmatic poor inhaler coordinate ability . Patients must 7 70 year age participate study .</brief_summary>
	<brief_title>Comparison Single-Dose Efficacy Albuterol Breath Activated Inhaler ( Albuterol-HFA-BAI ) Versus Albuterol Metered Dose Inhaler ( HFA-MDI ) ( Both Using Same Hydrofluoroalkane Propellant ) Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Albuterol</mesh_term>
	<criteria>Male female age 770 year old Asthma minimum 6 month duration Patients demonstrate poor inhalation/actuation coordination evaluate AIM Aerosol Inhalation Monitor . Reversible bronchoconstriction &gt; 12 % increase FEV1 cumulative dose 450 mcg albuterol The reversibility ( FEV1 ) &lt; 70 % follow administration initial 90 mcg albuterol Ability perform spirometry reproducibly Ability selfperform PEF determination report score diary Can tolerate withdrawal applicable medication screen Otherwise healthy individual Nonsmokers least two year Allergy sensitivity albuterol Exposure investigational drug within 30 day prior screen visit Continuous treatment Betablockers , MAO inhibitor , tricyclic antidepressant , and/or systemic corticosteroid Treated oral injectable corticosteroid within six week prior screen visit Unstable dose regimen require antileukotrienes , inhaled corticosteroid and/or inhale cromolyn and/or nedocromil Inability tolerate unwillingness comply require washout period applicable medication Hospitalization acute exacerbation asthma twice past year Treatment emergency room hospitalization asthmatic symptom within three month prior screen visit An upper respiratory tract infection and/or sinusitis associate exacerbation asthma unresolved three week prior screen visit History and/or presence clinically significant nonasthmatic acute chronic disease Known suspect substance abuse Previous enrollment IVAX Researchsponsored Albuterol HFA asthma study Other criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Asthma Poor Coordinators Asthma Inhalers</keyword>
</DOC>